New directions in therapy for ocular allergy.
el-Defrawy
S
S
University of Ottawa Eye Institute, Ottawa General Hospital, Ontario.
Jackson
W B
WB
D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016503:Drug Delivery Systems / Q000379:methods; D004804:Eosinophils / Q000276:immunology; D005128:Eye Diseases / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008407:Mast Cells / Q000276:immunology
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents